🇺🇸 FDA

Drug profile · INN

diphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)

VAXELIS

J07CA09
Patents linked
0
News articles
0

Quick answer

diphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed) (VAXELIS) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN diphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)
Brand VAXELIS
ATC code J07CA09

Frequently asked questions

What is diphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)?

diphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed) (VAXELIS) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for diphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)?

VAXELIS is a marketed brand name for diphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed). Check FDA Drugs@FDA for the current US label holder and prescribing information.